MCK Mckesson Corporation

  1. Stocks
  2. Healthcare
  3. NYSE: MCK

Price (delayed)

$858.9

Market cap

$100.14B

P/E Ratio

22.92

Dividend/share

$3.28

EPS

$37.47

Enterprise value

$106.68B

?
Relative Growth: Rel. Growth: 73
Relative Strength: Rel. Strength: 47
Relative Valuation: Rel. Valuation: 80
Relative Profitability: Rel. Profitability: 40

McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to ...

Highlights
The company's gross profit rose by 11% YoY and by 2.8% QoQ
The revenue is up by 9% year-on-year
The company's EPS rose by 49% YoY but it fell by 2.8% QoQ
MCK's net income is up by 45% YoY but it is down by 3.6% QoQ
MCK's equity has dropped by 116% year-on-year and by 95% since the previous quarter
The debt has grown by 36% since the previous quarter and by 18% year-on-year
Sector: Healthcare
Industry: Medical Distribution
Website: http://www.mckesson.com
Peers: CAH HSIC ACH

Key stats

What are the main financial stats of MCK

MCK stock price

How has the Mckesson stock price performed over time
Intraday
2.4%
1 week
-1.16%
1 month
3.63%
1 year
21.66%
YTD
4.71%
QTD
13.67%

Financial performance

How have Mckesson's revenue and profit performed over time
Revenue
$410.98B
Gross profit
$14.96B
Operating income
$6.5B
Net income
$4.59B
Gross margin
3.6%
Net margin
1.1%
Mckesson's operating income has increased by 47% YoY and by 4.6% from the previous quarter
MCK's net income is up by 45% YoY but it is down by 3.6% QoQ
The net margin has grown by 38% year-on-year but it has declined by 8% since the previous quarter
Mckesson's operating margin has increased by 33% YoY and by 7% from the previous quarter

Price vs fundamentals

How does MCK's price correlate with its fundamentals

Growth

What is Mckesson's growth rate over time

Valuation

What is Mckesson stock price valuation
MCK P/E details
P/E
22.92
P/B
N/A
P/S
0.25
EV/EBIT
17.71
EV/EBITDA
15.13
EV/Sales
0.26
The company's EPS rose by 49% YoY but it fell by 2.8% QoQ
The price to earnings (P/E) is 5% less than the 5-year quarterly average of 24.2
MCK's equity has dropped by 116% year-on-year and by 95% since the previous quarter
MCK's P/S is 25% above its 5-year quarterly average of 0.2 and 25% above its last 4 quarters average of 0.2
The revenue is up by 9% year-on-year

Efficiency

How efficient is Mckesson business performance
The return on invested capital has surged by 51% year-on-year but it has declined by 2.8% since the previous quarter
The return on assets has grown by 29% year-on-year but it has declined by 5% since the previous quarter
The company's return on sales rose by 25% YoY

Dividends

What is MCK's dividend history
Dividend details
DPS
$3.28
Dividend yield
0.38%
Payout ratio
8.8%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Mckesson financials performed over time
The total assets is 4.2% smaller than the total liabilities
Mckesson's total liabilities has increased by 11% YoY and by 10% from the previous quarter
The total assets has grown by 9% year-on-year and by 7% since the previous quarter
MCK's equity has dropped by 116% year-on-year and by 95% since the previous quarter
Mckesson's debt to equity has increased by 45% YoY and by 30% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.